Arimidex 1mg tablet is an anticancer drug with the ingredient Anastrozole. It belongs to the medication class known as aromatase inhibitors. The Arimidex tablet is used to treat hormone-dependent breast cancer in postmenopausal women. Aromatase inhibitors reduce estrogen levels by preventing an enzyme in adipose tissue from converting other hormones into estrogen. This medication helps to delay the recurrence of early-stage breast cancer.
The common side effects are nausea, vomiting, loss of appetite, fever, itching, inflammation of the joints (arthritis), bone loss (osteoporosis), bleeding from the vagina, hypersensitivity, and joint, stomach, and kidney pain.
If you are allergic to Anastrozole or its ingredients, tell your doctor before starting treatment with this medication. Tell your doctor if you are still experiencing menstruation and have not yet reached menopause, have osteoporosis, or have any liver or kidney problems. If you are lactose intolerant, consult your doctor before taking this medicine. Do not take medicine if you are pregnant or breastfeeding.
How common is the use of Arimidex 1mg tablets?Arimidex 1mg tablets are used to treat hormone-dependent breast cancer in postmenopausal women. It aims to treat postmenopausal breast cancer by stopping the growth of breast cancer cells, by lowering estrogen levels in the body, and by using an aromatase inhibitor to reduce estrogen levels in the body.
How do I take Arimidex 1mg tablets?Take the tablet with a glass of water to prevent calcium from entering the tablet. Take the tablet at least 30 minutes, and only taken on an empty stomach. Do not take more than once daily.
The most common side effects of Arimidex 1mg tablets are hot flashes, fatigue, mood changes, weakness, muscle pain, osteoporosis, and joint swelling or pain. Consult your doctor if these side effects persist or worsen.
How long has Arimidex 1mg taken?The effects of Arimidex 1mg tablets can be seen in a few days, depending on the dosage and the cause of the symptoms.
Some people taking Arimidex 1mg tablets may experience side effects such as nausea, headache, dizziness, depression, irregular heartbeat, nausea or dizziness, breast pain or tenderness, dark urine, or pain in the testicles. If you notice any of these symptoms, discuss them with your doctor.
How long have I been taking Arimidex 1mg?As of 2023, I have not been taking this medication for more than 3 years. I have gained weight and have been using an aromatase inhibitor since I was 12 years old. I have not had any side effects and I do not need to plan for or follow any regular dosing schedule.
How long have you been taking it?The effects of Arimidex 1mg tablets can be seen in a few days, but it is important to note that I have not been taking this medication for more than 3 years.
What vitamins are available with Arimidex 1mg?Vitamins C, E, and B12 are available with Arimidex 1mg, depending on the medication. Tell your doctor if you are allergic to any of the ingredients.
How do I store Arimidex 1mg?I have been taking Arimidex 1mg tablets for several years. Do not exceed the recommended dose.
What medications will be taken with Arimidex 1mg?If you are taking an aromatase inhibitor, such as anastrozole, let your doctor know about it. Tell your doctor if you are taking cyclophosphamide, doxazosin, orAlrightglemen.
What should I avoid when taking Arimidex 1mg?I avoid activities that require my body energy to produce, such as driving, and activities that cause unnecessary drowsiness (e.g., operating machinery).
I avoid foods that can make my symptoms worse. Avoid foods that can make your symptoms worse.
What should I avoid while taking Arimidex 1mg?If you are sexually active, do not take Arimidex 1mg tablets. Avoid alcoholic beverages, grapefruit juice, or tobacco products while taking Arimidex 1mg tablets.
Q: Does ARIMIDEX 1MG TABLET affect bone health?
A: Yes, ARIMIDEX 1MG TABLET acts by lowering the estrogen levels in the body, which is an important hormone to maintain bone health. Due to this, the mineral content of the bones decreases, and they may become less strong and more prone to fracture. Your doctor might ask you to take several tests to better assess and manage your condition.
Q: Can I stop taking ARIMIDEX 1MG TABLET on my own?
A: No, do not stop taking ARIMIDEX 1MG TABLET without the advice of your doctor. However, not taking the medicine at the recommended time may increase the risk of your breast cancer recurring.
Q: Is ARIMIDEX 1MG TABLET a form of chemotherapy?
A: No, ARIMIDEX 1MG TABLET acts by decreasing the estrogen levels in the body, which is a hormone. This in turn decreases the growth of cancer cells in breasts. ARIMIDEX 1MG TABLET is hormone therapy.
Q: Who should avoid taking ARIMIDEX 1MG TABLET?
A: ARIMIDEX 1MG TABLET is not recommended if you still have menstrual periods, are pregnant or planning to become pregnant, or are allergic to ARIMIDEX 1MG TABLET. Consult your doctor before taking ARIMIDEX 1MG TABLET.
Q: What if I forget to take a dose of ARIMIDEX 1MG TABLET?
A: If you forget to take a dose of ARIMIDEX 1MG TABLET, just take your next dose as normal. Do not take two doses of ARIMIDEX 1MG TABLET at the same time to make up for a forgotten dose.
Q: Can alcohol be consumed with ARIMIDEX 1MG TABLET?
A: It is best to avoid or limit alcohol intake when ARIMIDEX 1MG TABLET is taken, since alcohol can raise your risk of experiencing side effects from ARIMIDEX 1MG TABLET such as hot flashes or joint pain.
Q: Should calcium be taken with ARIMIDEX 1MG TABLET?
A: It is advisable to take calcium and vitamin D supplements while ARIMIDEX 1MG TABLET is taken since the medicine may cause bone loss as a side effect, which can be monitored by a bone mineral density (BMD) test if done every 1 to 2 years.
Q: Is ARIMIDEX 1MG TABLET safe to use with children?
A: ARIMIDEX 1MG TABLET is not recommended for use in children and adolescents under 18 years of age due to a lack of safety and effectiveness. Generally, breast cancer occurs in older women. However, consult your doctor for advice before taking ARIMIDEX 1MG TABLET.
Possible to start taking ARIMIDEX 1MG TABLET once daily as a safe method to prevent bone loss, other side effects, or as a form of radiation treatment may occur during treatment with ARIMIDEX 1MG TABLET (see section 4.4). Tell your doctor if your symptoms do not improve.Using ARIMIDEX 1MG TABLET with children
A: It is not recommended to take ARIMIDEX 1MG TABLET or any form of tyrosine-acks, as it may cause your treatment to not be effective or cause your symptoms to improve well. Your doctor may ask you to take several tests to identify and manage your condition.
Cautions
A: AT LEast 60 minutes before a meal, stop taking ARIMIDEX 1MG TABLET and contact your doctor. Your doctor will need to monitor your symptoms and make necessary changes to your treatment. Do not take ARIMIDEX 1MG TABLET if you suffer from asthma, chronic obstructive pulmonary disease (COPD), severe liver disease, or kidney disease. Your doctor will check your liver function after you stop taking ARIMIDEX 1MG TABLET.
Breast cancer is a common malady that affects millions of women worldwide. While there are several forms of breast cancer, one of the most common is breast cancer of the ovary, the primary form of breast cancer that develops in the ovary. Ovarian cancer is the most common form of breast cancer, affecting up to 50% of women across the globe. It is caused by a hormonal imbalance that leads to the development of breast cancer in postmenopausal women. Breast cancer has been a subject of ongoing research and clinical development since the 1960s. There are two types of breast cancer, ductal carcinoma (DC) and lobular carcinoma (LC) (). DC is more common and has a high rate of recurrence and metastasis (). These two types of breast cancer are more common in women than in men (). One of the major concerns is the high incidence of breast cancer in women of reproductive age, which can be associated with an increased risk of developing breast cancer. Women are at risk of developing breast cancer in women at a higher rate than men, especially in the late-life years. Breast cancer has been a topic of much interest for breast cancer researchers worldwide for the past two decades. A recent meta-analysis of observational breast cancer data concluded that there were no statistically significant differences between the overall survival time of women with DC and LC in the early- and early-stage stages (). In the early-stage stage, the overall survival time of DC patients was significantly longer than that of LC patients (). However, the survival time of LC patients was longer than that of DC patients (). The primary mechanism of breast cancer in LC patients is that of mutations in the oncogene, which is responsible for the development of DC and LC. In the late-stage stages, the overall survival time of LC patients was shorter than that of DC patients (). The exact mechanism of breast cancer in LC patients is not fully understood, but a possible role of the oncogene in LC development is still being investigated. As a result of this, it is expected that the development of breast cancer will continue during the late-stage stages of breast cancer. It is also expected that the development of LC will continue in the late-stage stages of breast cancer in the early-stage stages of breast cancer, and it is expected that the development of LC will continue in the late-stage stages of breast cancer. There is also evidence that the risk of developing breast cancer in LC patients is higher than that in DC patients (). A recent meta-analysis of observational breast cancer data concluded that the risk of breast cancer in LC patients was higher than that in DC patients (). However, it is not known if there is a correlation between the risk of developing breast cancer in LC patients and the risk of developing breast cancer in DC patients. In addition, the risk of developing breast cancer in LC patients is higher than that in DC patients, and the risk of developing breast cancer in LC patients is higher than that in DC patients (). Although the exact mechanism of breast cancer in LC patients is not fully understood, the risk of developing breast cancer in LC patients appears to be higher than that in DC patients (). The development of breast cancer in LC patients appears to be associated with a higher rate of recurrence than in DC patients (). The mechanism of breast cancer in LC patients is not completely understood, but there is a possible association between the risk of developing breast cancer in LC patients and the risk of developing breast cancer in DC patients (). The development of LC may be associated with an increase in the number of breast cancer-related deaths (). A recent meta-analysis of observational breast cancer data concluded that the risk of developing breast cancer in LC patients is higher than in DC patients ().
The use of aromatase inhibitors (AIs) in the treatment of breast cancer is one of the most common types of breast cancer and the most prescribed drugs for breast cancer treatment. AIs include aromatase inhibitors (AI) such as anastrozole (Arimidex), letrozole (Femara), and letrozole (Femara XR). These AIs are used in breast cancer treatment and have been shown to be effective in reducing the recurrence of breast cancer. The use of AI in the treatment of breast cancer is also associated with a higher risk of breast cancer in women and a higher risk of developing breast cancer in women (). In addition, AI has also been found to increase the risk of breast cancer in women and has also been shown to reduce the risk of breast cancer in women ().
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife.com.auDate added:21 May 2022othing to indicate that this product has anydocumented or verified claimsigenousDescription: Arimidex Anastrozole (1mg) 30 Tablets (1 tablet) is a branded anabolic steroid that is used to treat breast cancer in post-menopausal women. Arimidex is manufactured by Healthylife Pharmacy, an independently owned and operated pharmacy business. Arimidex is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. Healthylife Pharmacy, an independently owned and operated pharmacy business is a division of Bazaarvoice. Healthylife does not endorse, recommend, or recommend the efficacy, safety or quality of these products oreller surprisesherboboxfor use in women with breast cancer to avoid the risk of a recurrence of the disease.
Stade de France Pharmacy